More informative abstracts of articles describing clinical practice guidelines

Robert S A Hayward, Mark C. Wilson, Sean R. Tunis, Eric B Bass, Haya R. Rubin, R. Brian Haynes

Research output: Contribution to journalArticle

Abstract

Recommendations are proposed for preparing more informative abstracts of articles describing clinical practice guidelines. Information about the development and content of guidelines should be summarized with the following structure. Objective: a succinct statement of the objective of the guideline, including the targeted health problem, the targeted patients and providers, and the main reason for developing recommendations concerning this problem for this population. Options: principal practice options that were considered in formulating the guideline. Outcomes: significant health and economic outcomes identified as potential consequences of the practice options. Evidence: methods used to gather, select, and synthesize evidence, and the date of the most recent evidence obtained. Values: persons and methods used to assign values (relative importance) to potential outcomes of alternative practice options. Benefits, Harms, and Costs: the type and magnitude of the main benefits, harms, and costs that are expected to result from guideline implementation. Recommendations: a brief and specific list of key recommendations. Validation: the results of any external review, comparison with guidelines developed by other groups, or clinical testing of guideline use. Sponsors: key persons or groups that developed, funded, or endorsed the guideline. Abstracts adhering to these recommendations could enhance readers' ability to appraise the applicability, importance, and validity of guidelines for specific providers, patients, and settings. More informative abstracts could also promote the use of more explicit methods of guideline development, more consistent reporting of guideline documents, and the more appropriate use of guidelines by clinicians.

Original languageEnglish (US)
Pages (from-to)731-737
Number of pages7
JournalAnnals of Internal Medicine
Volume118
Issue number9
StatePublished - May 1 1993

Fingerprint

Practice Guidelines
Guidelines
Cost-Benefit Analysis
Health
Economics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hayward, R. S. A., Wilson, M. C., Tunis, S. R., Bass, E. B., Rubin, H. R., & Haynes, R. B. (1993). More informative abstracts of articles describing clinical practice guidelines. Annals of Internal Medicine, 118(9), 731-737.

More informative abstracts of articles describing clinical practice guidelines. / Hayward, Robert S A; Wilson, Mark C.; Tunis, Sean R.; Bass, Eric B; Rubin, Haya R.; Haynes, R. Brian.

In: Annals of Internal Medicine, Vol. 118, No. 9, 01.05.1993, p. 731-737.

Research output: Contribution to journalArticle

Hayward, RSA, Wilson, MC, Tunis, SR, Bass, EB, Rubin, HR & Haynes, RB 1993, 'More informative abstracts of articles describing clinical practice guidelines', Annals of Internal Medicine, vol. 118, no. 9, pp. 731-737.
Hayward RSA, Wilson MC, Tunis SR, Bass EB, Rubin HR, Haynes RB. More informative abstracts of articles describing clinical practice guidelines. Annals of Internal Medicine. 1993 May 1;118(9):731-737.
Hayward, Robert S A ; Wilson, Mark C. ; Tunis, Sean R. ; Bass, Eric B ; Rubin, Haya R. ; Haynes, R. Brian. / More informative abstracts of articles describing clinical practice guidelines. In: Annals of Internal Medicine. 1993 ; Vol. 118, No. 9. pp. 731-737.
@article{f24c03b74881436db09fa765f1b3b826,
title = "More informative abstracts of articles describing clinical practice guidelines",
abstract = "Recommendations are proposed for preparing more informative abstracts of articles describing clinical practice guidelines. Information about the development and content of guidelines should be summarized with the following structure. Objective: a succinct statement of the objective of the guideline, including the targeted health problem, the targeted patients and providers, and the main reason for developing recommendations concerning this problem for this population. Options: principal practice options that were considered in formulating the guideline. Outcomes: significant health and economic outcomes identified as potential consequences of the practice options. Evidence: methods used to gather, select, and synthesize evidence, and the date of the most recent evidence obtained. Values: persons and methods used to assign values (relative importance) to potential outcomes of alternative practice options. Benefits, Harms, and Costs: the type and magnitude of the main benefits, harms, and costs that are expected to result from guideline implementation. Recommendations: a brief and specific list of key recommendations. Validation: the results of any external review, comparison with guidelines developed by other groups, or clinical testing of guideline use. Sponsors: key persons or groups that developed, funded, or endorsed the guideline. Abstracts adhering to these recommendations could enhance readers' ability to appraise the applicability, importance, and validity of guidelines for specific providers, patients, and settings. More informative abstracts could also promote the use of more explicit methods of guideline development, more consistent reporting of guideline documents, and the more appropriate use of guidelines by clinicians.",
author = "Hayward, {Robert S A} and Wilson, {Mark C.} and Tunis, {Sean R.} and Bass, {Eric B} and Rubin, {Haya R.} and Haynes, {R. Brian}",
year = "1993",
month = "5",
day = "1",
language = "English (US)",
volume = "118",
pages = "731--737",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "9",

}

TY - JOUR

T1 - More informative abstracts of articles describing clinical practice guidelines

AU - Hayward, Robert S A

AU - Wilson, Mark C.

AU - Tunis, Sean R.

AU - Bass, Eric B

AU - Rubin, Haya R.

AU - Haynes, R. Brian

PY - 1993/5/1

Y1 - 1993/5/1

N2 - Recommendations are proposed for preparing more informative abstracts of articles describing clinical practice guidelines. Information about the development and content of guidelines should be summarized with the following structure. Objective: a succinct statement of the objective of the guideline, including the targeted health problem, the targeted patients and providers, and the main reason for developing recommendations concerning this problem for this population. Options: principal practice options that were considered in formulating the guideline. Outcomes: significant health and economic outcomes identified as potential consequences of the practice options. Evidence: methods used to gather, select, and synthesize evidence, and the date of the most recent evidence obtained. Values: persons and methods used to assign values (relative importance) to potential outcomes of alternative practice options. Benefits, Harms, and Costs: the type and magnitude of the main benefits, harms, and costs that are expected to result from guideline implementation. Recommendations: a brief and specific list of key recommendations. Validation: the results of any external review, comparison with guidelines developed by other groups, or clinical testing of guideline use. Sponsors: key persons or groups that developed, funded, or endorsed the guideline. Abstracts adhering to these recommendations could enhance readers' ability to appraise the applicability, importance, and validity of guidelines for specific providers, patients, and settings. More informative abstracts could also promote the use of more explicit methods of guideline development, more consistent reporting of guideline documents, and the more appropriate use of guidelines by clinicians.

AB - Recommendations are proposed for preparing more informative abstracts of articles describing clinical practice guidelines. Information about the development and content of guidelines should be summarized with the following structure. Objective: a succinct statement of the objective of the guideline, including the targeted health problem, the targeted patients and providers, and the main reason for developing recommendations concerning this problem for this population. Options: principal practice options that were considered in formulating the guideline. Outcomes: significant health and economic outcomes identified as potential consequences of the practice options. Evidence: methods used to gather, select, and synthesize evidence, and the date of the most recent evidence obtained. Values: persons and methods used to assign values (relative importance) to potential outcomes of alternative practice options. Benefits, Harms, and Costs: the type and magnitude of the main benefits, harms, and costs that are expected to result from guideline implementation. Recommendations: a brief and specific list of key recommendations. Validation: the results of any external review, comparison with guidelines developed by other groups, or clinical testing of guideline use. Sponsors: key persons or groups that developed, funded, or endorsed the guideline. Abstracts adhering to these recommendations could enhance readers' ability to appraise the applicability, importance, and validity of guidelines for specific providers, patients, and settings. More informative abstracts could also promote the use of more explicit methods of guideline development, more consistent reporting of guideline documents, and the more appropriate use of guidelines by clinicians.

UR - http://www.scopus.com/inward/record.url?scp=0027465719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027465719&partnerID=8YFLogxK

M3 - Article

C2 - 8460861

AN - SCOPUS:0027465719

VL - 118

SP - 731

EP - 737

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 9

ER -